Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Statistics

Total Valuation

NTLA has a market cap or net worth of $1.05 billion. The enterprise value is $208.02 million.

Market Cap	1.05B
Enterprise Value	208.02M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, before market open.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

NTLA has 101.85 million shares outstanding. The number of shares has increased by 11.02% in one year.

Current Share Class	101.85M
Shares Outstanding	101.85M
Shares Change (YoY)	+11.02%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	92.58%
Float	100.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.99
Forward PS	25.01
PB Ratio	1.09
P/TBV Ratio	1.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.73, with a Debt / Equity ratio of 0.11.

Current Ratio	6.73
Quick Ratio	6.31
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.23% and return on invested capital (ROIC) is -30.28%.

Return on Equity (ROE)	-52.23%
Return on Assets (ROA)	-27.81%
Return on Invested Capital (ROIC)	-30.28%
Return on Capital Employed (ROCE)	-50.36%
Revenue Per Employee	$81,913
Profits Per Employee	-$992,935
Employee Count	526
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.03% in the last 52 weeks. The beta is 1.83, so NTLA's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	-58.03%
50-Day Moving Average	12.44
200-Day Moving Average	19.57
Relative Strength Index (RSI)	41.53
Average Volume (20 Days)	3,145,206

Short Selling Information

The latest short interest is 24.06 million, so 23.62% of the outstanding shares have been sold short.

Short Interest	24.06M
Short Previous Month	21.67M
Short % of Shares Out	23.62%
Short % of Float	24.00%
Short Ratio (days to cover)	8.36

Income Statement

In the last 12 months, NTLA had revenue of $43.09 million and -$522.28 million in losses. Loss per share was -$5.44.

Revenue	43.09M
Gross Profit	-415.33M
Operating Income	-537.71M
Pretax Income	-508.80M
Net Income	-522.28M
EBITDA	-527.52M
EBIT	-537.71M
Loss Per Share	-$5.44

Balance Sheet

The company has $658.11 million in cash and $101.62 million in debt, giving a net cash position of $843.06 million or $8.28 per share.

Cash & Cash Equivalents	658.11M
Total Debt	101.62M
Net Cash	843.06M
Net Cash Per Share	$8.28
Equity (Book Value)	962.62M
Book Value Per Share	9.46
Working Capital	605.22M

Cash Flow

In the last 12 months, operating cash flow was -$356.74 million and capital expenditures -$6.32 million, giving a free cash flow of -$363.06 million.

Operating Cash Flow	-356.74M
Capital Expenditures	-6.32M
Free Cash Flow	-363.06M
FCF Per Share	-$3.56

Margins

Gross Margin	n/a
Operating Margin	-1,247.99%
Pretax Margin	-1,212.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NTLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.02%
Shareholder Yield	-11.02%
Earnings Yield	-49.69%
FCF Yield	-34.54%

Analyst Forecast

The average price target for NTLA is $50.53, which is 389.63% higher than the current price. The consensus rating is "Buy".

Price Target	$50.53
Price Target Difference	389.63%
Analyst Consensus	Buy
Analyst Count	18
Revenue Growth Forecast (5Y)	102.67%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NTLA has an Altman Z-Score of 3.61 and a Piotroski F-Score of 1.

Altman Z-Score	3.61
Piotroski F-Score	1